Service Hotline: 400-826- 0806

News center


[Partner] Connaught Jian Hua, Tian Guang real powerful combination: TK (Orelabrutinib) + CD20 in co

Date: 2019-08-29
Views: 54

Note: Beijing Tian-Guang real Biotechnology Co., Ltd. of Paradise Valley invested enterprises

Recently, Connaught Jianhua, day wide real BTK (Orelabrutinib) + CD20 with relapsed / refractory CD20 + B cell lymphoma obtained CDE acquiescence.

Connaught-China (Innocare)

Co-founded by world-renowned structural biologist Prof. Shi Yigong and bio-pharmaceutical industry excellence in corporate management Dr. Cui Jisong. We focused on the treatment of cancer and autoimmune diseases in the field of a class of development of new drugs for Chinese patients with high incidence of lymphoma, liver cancer, bile duct cancer and other solid tumors and rheumatoid arthritis and systemic lupus erythematosus and other autoimmune diseases.

The company product line pipeline:

Treatment of systemic lupus erythematosus and rheumatoid arthritis drug development targeting ICP-022's 'successful' Thirteen Five 'National Key New Drug Creation of special project support.

It is reported, ICP-022 in the lymphoma and mantle cell lymphoma, chronic leukemia after completion of Phase II trial, the application data will be the priority review, approval conditions listed.

Product line except a BTK inhibitor, FGFR inhibitor as well as two, respectively ICP105 and ICP-192.

According to the text, probably counted under valuation:

Sunny Investments Limited (Swiss Investment Company) is the largest shareholder of Novo Cheng Jian Hua. According to microblogging Research_ medicine man -Daniel data, a simple calculation after April Connaught-China valued at about $ 860 million. (For reference only) is currently preparing an IPO.

Tian-Guang real

Beijing Tian-Guang real Biotechnology Co., Ltd. (Beijing Mabworks Biotech Co.Ltd)

In is a clinical-stage biopharmaceutical company, with a leading antibody drug development and industrialization of technological capabilities and formed a perfect technology system.

MIL62 it is rituximab (MabThera) and Alto natalizumab (GA101) of product superiority (me-better). MIL62 is the third generation aCD20 antibody fucose knockout proven effective in vitro pharmacodynamics of rituximab imported products, 100% fucose knockout, better than GA101 only 50% of the knock-out level. November 2015 submitted a clinical application to the CFDA, mainly indicated for chronic lymphocytic leukemia. October 31, 2016 to obtain this document clinical, clinical documents of approval: 2016L09586.

 (Reprinted from: Drug newsletters official micro-channel public number)

Partners: Paradise Valley in March 2019 to invest in Beijing Tian-Guang real Biotechnology Co., Ltd. by PE funds.

News / Related news More
2021 - 01 - 18
On January 18, 2021, Tianneng Battery Group Co., Ltd. (hereinafter referred to as 'Tianneng shares', stock code: 688819), an investment company invested by Paradise Silicon Valley Holdings' parent company, Silicon Valley Paradise, officially landed on the Science and Technology Innovation Board.Tianneng Co., Ltd. was established in 2003. It is a green power battery business for electri...
2017 - 11 - 30
CAI Gangqing, president and deputy secretary of the Party Committee of Anji Industrial Investment Development Group (IIDG) paid a visit to TTGG with 5 colleagues on the afternoon of 30th November. ZOU Jin, general manager and deputy secretary of the Party Committee of IIDG, FANG Jun, vice-general manager, and other department heads of IIDG attended the discussion. Our managing partner ZHANG Y...
2017 - 11 - 28
Zvi Heifetz, Israeli Ambassador to China, paid a visit to TTGG along with his wife on the evening of 28th November 2017. They were greeted by TTGG’s president YU Baohong. ZHANG Yu and GUO Feng, managing partners of TTGG, LI Xiang, general-manager of Investment Management Department, and other department heads also took part in the meeting.After greeting, YU briefly introduced TTGG’s hist...
2017 - 08 - 14
With the accelerating rhythm of the society, more and more white-collars are feeling stressed under modern work environments. In fact, such stress primarily results from the target-oriented time management. The key factors facilitating their abilities to improve time management efficiency and effectiveness are: how to find the causes of inefficiency, how to distinguish between the important things...
Copyright © 2016 - 2019 Zhejiang Paradise Silicon Valley Asset Management Group Co., Ltd










  • 400-826-0806